SAMSIC MEDICAL ILE DE FRANCE : revenue, balance sheet and financial ratios

SAMSIC MEDICAL ILE DE FRANCE is a French company founded 11 years ago, specialized in the sector Activités des agences de travail temporaire . Based in PARIS (75009), this company of category GE shows in 2024 a revenue of 49.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SAMSIC MEDICAL ILE DE FRANCE (SIREN 811158328)
Indicator 2024 2023 2022 2021 2020 2019 2017 2016
Revenue 49 780 766 € 37 654 938 € 21 918 688 € 23 318 284 € 17 235 842 € 5 309 474 € 4 386 422 € 4 275 921 €
Net income 5 655 939 € 2 799 748 € 887 678 € 1 108 878 € 1 363 912 € 193 795 € 168 101 € 161 339 €
EBITDA 8 153 740 € 3 785 357 € 1 210 784 € 1 514 749 € 1 885 130 € 238 273 € 171 342 € 162 129 €
Net margin 11.4% 7.4% 4.0% 4.8% 7.9% 3.6% 3.8% 3.8%

Revenue and income statement

In 2024, SAMSIC MEDICAL ILE DE FRANCE achieves revenue of 49.8 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +35.9%. Vs 2023, growth of +32% (37.7 M€ -> 49.8 M€). After deducting consumption (0 €), gross margin stands at 49.8 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 8.2 M€, representing 16.4% of revenue. Positive scissor effect: EBITDA margin improves by +6.3 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 5.7 M€, i.e. 11.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

49 780 766 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

49 780 766 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

8 153 740 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

7 165 843 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

5 655 939 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

16.4%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 676%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 8.6 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 11.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

676.028%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

10.078%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

11.631%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

8.617

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

91.6%

Solvency indicators evolution
SAMSIC MEDICAL ILE DE FRANCE

Sector positioning

Debt ratio
676.03 2024
2022
2023
2024
Q1: 0.0
Med: 2.73
Q3: 26.78
Watch

In 2024, the debt ratio of SAMSIC MEDICAL ILE DE FRANCE (676.03) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
10.08% 2024
2022
2023
2024
Q1: 11.73%
Med: 25.56%
Q3: 44.76%
Average

In 2024, the financial autonomy of SAMSIC MEDICAL ILE DE FRANCE (10.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
8.62 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.27 years
Watch

In 2024, the repayment capacity of SAMSIC MEDICAL ILE DE FRANCE (8.62) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 441.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 10.8x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

441.848

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

10.786

Liquidity indicators evolution
SAMSIC MEDICAL ILE DE FRANCE

Sector positioning

Liquidity ratio
441.85 2024
2022
2023
2024
Q1: 111.16
Med: 138.5
Q3: 192.32
Excellent +23 pts over 3 years

In 2024, the liquidity ratio of SAMSIC MEDICAL ILE DE FRANCE (441.85) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
10.79x 2024
2022
2023
2024
Q1: -0.69x
Med: 0.0x
Q3: 1.34x
Excellent

In 2024, the interest coverage of SAMSIC MEDICAL ILE DE FRANCE (10.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 61 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 354 days. Excellent situation: suppliers finance 293 days of the operating cycle (retail model). Overall, WCR represents 432 days of revenue, i.e. 59.7 M€ to permanently finance. Over 2016-2024, WCR increased by +6399%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

59 672 702 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

61 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

354 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

432 j

WCR and payment terms evolution
SAMSIC MEDICAL ILE DE FRANCE

Positioning of SAMSIC MEDICAL ILE DE FRANCE in its sector

Comparison with sector Activités des agences de travail temporaire

Valuation estimate

Based on 135 transactions of similar company sales (all years), the value of SAMSIC MEDICAL ILE DE FRANCE is estimated at 11 507 330 € (range 5 914 877€ - 26 977 174€). With an EBITDA of 8 153 740€, the sector multiple of 2.0x is applied. The price/revenue ratio is 0.08x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
135 transactions
5914k€ 11507k€ 26977k€
11 507 330 € Range: 5 914 877€ - 26 977 174€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
8 153 740 € × 2.0x
Estimation 16 533 843 €
7 924 739€ - 38 949 835€
Revenue Multiple 30%
49 780 766 € × 0.08x
Estimation 3 829 760 €
3 005 587€ - 6 846 583€
Net Income Multiple 20%
5 655 939 € × 1.8x
Estimation 10 457 404 €
5 254 159€ - 27 241 410€
How is this estimate calculated?

This estimate is based on the analysis of 135 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des agences de travail temporaire )

Compare SAMSIC MEDICAL ILE DE FRANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des agences de travail temporaire

Frequently asked questions about SAMSIC MEDICAL ILE DE FRANCE

What is the revenue of SAMSIC MEDICAL ILE DE FRANCE ?

The revenue of SAMSIC MEDICAL ILE DE FRANCE in 2024 is 49.8 M€.

Is SAMSIC MEDICAL ILE DE FRANCE profitable?

Yes, SAMSIC MEDICAL ILE DE FRANCE generated a net profit of 5.7 M€ in 2024.

Where is the headquarters of SAMSIC MEDICAL ILE DE FRANCE ?

The headquarters of SAMSIC MEDICAL ILE DE FRANCE is located in PARIS (75009), in the department Paris.

Where to find the tax return of SAMSIC MEDICAL ILE DE FRANCE ?

The tax return of SAMSIC MEDICAL ILE DE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SAMSIC MEDICAL ILE DE FRANCE operate?

SAMSIC MEDICAL ILE DE FRANCE operates in the sector Activités des agences de travail temporaire (NAF code 78.20Z). See the 'Sector positioning' section above to compare the company with its competitors.